Good morning. The Peter Mandelson story keeps unfolding. Peter Walker explains here what is in the latest release of documents, and Henry Dyer takes a look at the key papers missing from the latest disclosures. Today we are covering another major story: Palantir.
Few companies attract controversy more than Palantir. Since the pandemic, the US data analytics company has grown voraciously, using its AI-driven software to make sense of intractable datasets for customers around the world. For the NHS, it analyses patient records; for the US military, it’s focused on targets in Iran. Palantir’s products are widely used, with the business now worth $375bn.
